News
Entertainment
Science & Technology
Life
Culture & Art
Hobbies
News
Entertainment
Science & Technology
Culture & Art
Hobbies
Hospital M&A Has Hit the Brakes — But Activity Could Pick Up in the Second Half of 2025 - MedCity News
Hospital M&A activity slowed quite a bit in the first half of 2025, with deal volume and transacted revenue falling sharply amid economic uncertainty and sweeping policy changes. While traditional mergers may remain sluggish, analysts expect a rise in outpatient partnerships and rural hospital conversions toward the end of the year.
AbbVie Pays $700M for Drug Engineered to Overcome Resistance in Multiple Myeloma - MedCity News
AbbVie has acquired rights to a multispecific antibody that IGI Therapeutics designed to bind to three targets to treat multiple myeloma. Early Phase 1 results showed encouraging responses in a heavily pretreated patient population and a favorable safety profile.
Is Your AI-Driven Healthcare Startup Ready for New Investment? Apply to INVEST Digital Health Pitch Perfect Today. - MedCity News
We're getting close to the July 19 deadline for submissions. Don't miss this opportunity to pitch your company to a team of investors at INVEST Digital Health in Dallas on September 18!
Merck Breathes Life Into Its Respiratory Prospects With $10B Deal to Buy Verona Pharma - MedCity News
Verona Pharma brings to Merck the inhaled drug Ohtuvayre, which is FDA approved as a treatment for chronic obstructive pulmonary disease. While Ohtuvayre is projected to become a blockbuster product in COPD alone, its potential extends to other respiratory disorders as well.
Mandatory by 2026: 5 Ways to Prepare for CMS’ TEAM Payment Model - MedCity News
For hospitals and health systems, the challenge is steep, but so is the opportunity. TEAM offers a framework to deliver more coordinated, cost-effective, and patient-focused care. Those who prepare now will be far better positioned to thrive in a value-based future.
MedCity Pivot Podcast: Why Blood Pressure Monitoring Is Due for A New Era - MedCity News
CoraVie Medical CEO Aimee Garza and Dr. Michael Bloch, a hypertension specialist and clinical advisor for the startup, talk about why the healthcare industry needs a better approach to blood pressure monitoring. CoraVie is developing an implantable device that measures patients’ blood pressure, operating in a similar way to continuous glucose monitors. Watch or listen now!
When Cost Blocks Care: Why Medication Affordability Is the Next Frontier in Patient Care - MedCity News
Every day, patients are making agonizing choices to skip medications due to cost, and the fallout is evident in worsening health and avoidable hospitalizations. Health systems are in a prime position to break this cycle by acting as advocates for their patients’ financial as well as physical well-being.
The Future of Surgery: Bridging Innovation and Collaboration - MedCity News
The industry needs smart conversations that challenge assumptions and invite the full spectrum of voices to the table to ensure technology evolves in a way that’s not only clinically sound, but ethically aligned with what patients and providers need most.
Novartis Drug Becomes First Malaria Therapy for Newborns and Infants - MedCity News
Novartis malaria drug Coartem has expanded its approval to include babies. The combination drug, originally formulated as a tablet, has a new dose strength and formulation designed for treating newborns and young infants who develop malarial infections.
Samsung Deepens Healthcare Bet With Xealth Acquisition - MedCity News
Samsung announced plans to acquire Xealth, a startup that helps hospitals integrate digital tools into clinical workflows, as part of its broader push into U.S. healthcare. The deal reflects growing provider demand for tech solutions and comes amid newfound optimism in the digital health exit market.
KalVista Drug Gets FDA Approval for Treating Acute Swelling Attacks From Rare Disease - MedCity News
KalVista Pharmaceuticals’ Ekterly is now FDA approved for treating acute swelling attacks from hereditary angioedema. The KalVista tablet provides an alternative to injectable or infused HAE medications from companies such as Takeda Pharmaceutical and CSL Behring.
The Secret To Improved Population Health Management May Be In Our Pockets - MedCity News
The rapid advances in AI and smartphone technologies hold promise for many stakeholders in the healthcare system — providers, payers, pharmaceutical drugmakers and public health agencies — that need to understand what's happening with the patient in real time.
Debunked Episode 17: Is Big Pharma Prepared for Impact of Trump Administration's Health Policies? - MedCity News
The Trump administration's healthcare policy changes from the gutting of medical research grants to changes on the CDC vaccine board were the focus of the discussion on the latest episode of the Debunked Podcast with MedCity News Editor-in-Chief Arundhati Parmar and Samir Batra, managing partner of Health Innovation Pitch.
Breaking the Cycle: Unlocking the Untapped Opportunities in Healthcare Innovation - MedCity News
We’ve seen how transformative innovation can be when supported by focused investment. But if we want to continue advancing healthcare in meaningful ways, we must expand our lens and invest in the spaces that have been left behind.
Digital Health Funding in H1 2025: Market Stabilizes, AI Dominates and Exits Return - MedCity News
Digital health funding held steady in the first half of 2025, with AI-focused startups capturing the majority of capital and driving rapid adoption among providers. The digital health space also saw two long-awaited IPOs as well as rising M&A activity, which are two signals of market maturity — but looming policy shifts may challenge long-term growth.
Hospitals Are Investing in AI — How Can They Evaluate ROI? - MedCity News
AI doesn’t need to be a black box — and hospitals don’t need to invest based on blind faith. With the right structure, questions, and metrics in place, healthcare leaders can cut through the hype and make decisions that actually drive value.
How Microsoft Is Sparking Innovation in Rural Hospitals - MedCity News
Rural hospitals are facing growing cybersecurity threats and digital demands but often lack the resources to respond — a gap Microsoft is working to close through discounted tools, free training and an AI innovation lab. The tech giant’s rural health initiative has reached more than 700 hospitals so far.
Why HIPAA Compliance Is Both a Challenge and Opportunity for EMS Providers - MedCity News
From mobile documentation to emergency handoffs, EMS providers handle sensitive patient information in fast-moving environments. Understanding how HIPAA applies — and how to comply — can improve care, reduce risk, and build systemwide trust.
Blockbuster Novartis Drug Fails Key Test Hoped to Expand Its Use to Rare Blood Vessel Disorder - MedCity News
Novartis’s Cosentyx failed to beat a placebo in a Phase 3 clinical trial in giant cell arteritis. The antibody drug was being developed as an alternative to Roche and AbbVie drugs whose approved uses include treating this autoimmune disorder affecting blood vessels.
With FDA Nod in Lung Cancer, Dizal Now Aims to Best a J&J Drug and Succeed Where Takeda Fell Short - MedCity News
Dizal Pharmaceutical’s Zegfrovy is now FDA approved for treating non-small cell lung cancer driven by a particular rare genetic signature. Johnson & Johnson drug Rybrevant already addresses this genetic signature as an earlier line of therapy, but Dizal executives contend their drug offers the potential for better safety and efficacy.
From Magic Bullets to Medical Insights: How RFK Jr.'s Critique Shapes the Future of Pharma Advertising - MedCity News
But where do truth and trust originate in healthcare marketing? They emerge from various sources such as digital advertising, educational campaigns, patient journeys, and partnerships with healthcare providers who uphold truth in advertising standards.
Eko Health’s AI for Cardiac Diagnoses Earns CMS Reimbursement Rate - MedCity News
This week, CMS established a reimbursement code for Eko Health’s AI platform, which seeks to aid clinicians in the diagnosis of heart conditions. The goal behind the technology is to help catch heart disease earlier, when it’s easier to treat, and to make high quality diagnostic care more accessible.
What Administering My Father’s Home Infusions for 10 Years Taught Me About Improving Chronic Illness Care - MedCity News
It became clear to me that if my father’s life could be drastically improved with routine at-home care, so could many others. The next frontier in healthcare isn't just about new medications or diagnostic tools; it's about reimagining how and where we deploy our existing clinical expertise.
From Hype to Impact: How Pharma Can Use Agentic AI to Drive Efficiency and Trust - MedCity News
Success with agentic AI won’t come from racing to adopt the flashiest tools. It will come from strategic alignment, understanding where AI can create real value, mitigating risk through thoughtful implementation, and ensuring transparency and oversight at every step.
Organon Stops Work on Endometriosis Drug After Failure in Phase 2 Test - MedCity News
Organon said OG-6219 did not beat a placebo in a mid-stage clinical trial whose main goal was to measure the change in pelvic pain caused by endometriosis. The twice-daily pill came from Organon’s 2021 acquisition of Forendo Pharma.